LK
Insider
Lori Anne Kunkel
DirectorLori Anne Kunkel (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $505K of ELVN (10,000 sh across 2 lots, as filed), executed Jul 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$772K
shares × price, as filed
Last traded
Jul 6
Filed Jul 8
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $772K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$505K10,000 sh across 2 lots
Exec Jul 6
Filed Jul 8 · 5:15 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $267K
7,779 sh × $34.28
Exec Jun 5
Filed Jun 9 · 5:30 PM ET